XERIS BIOPHARMA HOLDINGS INC (XERS) Institutional Shareholders
XERIS BIOPHARMA HOLDINGS INC (XERS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $851.74M in XERS holdings during the latest filing period.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of XERS tracked by InsiderSet, reporting ownership valued at approximately $115.04M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $119.11M, representing an estimated gain of +3.54% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 51% of the total disclosed XERS value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., D. E. Shaw & Co., Inc., Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in XERIS BIOPHARMA HOLDINGS INC (XERS).
This page ranks the largest institutional XERS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
233
Total Reported Value
$851.74M
Largest Holder
Blackrock, Inc.
Largest Position
$115.04M
Insider Transactions (90d)
12
Latest Filing Quarter
Q2 2026
New Institutional Positions
60
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 14,525,539 | $115,042,270 | $119,109,420 | +$4,067,150 | +3.54% | |
| D. E. Shaw & Co., Inc. | 0.04% | 7,804,758 | $61,813,683 | $63,999,016 | +$2,185,333 | +3.54% | |
| Vanguard Capital Management Llc | 0.00% | 7,340,229 | $58,134,614 | $60,189,878 | +$2,055,264 | +3.54% | |
| State Street Corp | 0.00% | 4,821,566 | $38,186,803 | $39,536,841 | +$1,350,038 | +3.54% | |
| Geode Capital Management, Llc | 0.00% | 4,718,183 | $37,374,872 | $38,689,101 | +$1,314,229 | +3.52% | |
| Nuveen, Llc | 0.01% | 4,385,141 | $34,730,316 | $35,958,156 | +$1,227,840 | +3.54% | |
| Rosalind Advisors, Inc. | 8.65% | 2,908,981 | $23,039,130 | $23,853,644 | +$814,514 | +3.54% | |
| Qube Research & Technologies Ltd | 0.03% | 2,893,749 | $22,918,492 | $23,728,742 | +$810,250 | +3.54% | |
| Vanguard Portfolio Management Llc | 0.00% | 2,626,208 | $20,799,567 | $21,534,906 | +$735,339 | +3.54% | |
| Wellington Management Group Llp | 0.00% | 2,365,103 | $18,731,616 | $19,393,845 | +$662,229 | +3.54% | |
| Morgan Stanley | 0.00% | 2,337,096 | $18,509,800 | $19,164,187 | +$654,387 | +3.54% | |
| Legal & General Group Plc | 0.00% | 2,012,792 | $15,941,313 | $16,504,894 | +$563,581 | +3.54% | |
| Armistice Capital, Llc | 0.43% | 1,958,702 | $15,512,920 | $16,061,356 | +$548,436 | +3.54% | |
| Two Sigma Investments, Lp | 0.01% | 1,885,503 | $14,933,184 | $15,461,125 | +$527,941 | +3.54% | |
| Parkman Healthcare Partners Llc | 1.47% | 1,807,621 | $14,316,358 | $14,822,492 | +$506,134 | +3.54% | |
| Algert Global Llc | 0.16% | 1,742,942 | $13,804,101 | $14,292,124 | +$488,023 | +3.54% | |
| Northern Trust Corp | 0.00% | 1,597,749 | $12,654,172 | $13,101,542 | +$447,370 | +3.54% | |
| Goldman Sachs Group Inc | 0.00% | 1,594,072 | $12,625,051 | $13,071,390 | +$446,339 | +3.54% | |
| Aqr Capital Management Llc | 0.00% | 1,540,985 | $12,204,601 | $12,636,077 | +$431,476 | +3.54% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,492,367 | $11,819,547 | $12,237,409 | +$417,862 | +3.54% | |
| Federated Hermes, Inc. | 0.02% | 1,434,433 | $11,360,709 | $11,762,351 | +$401,642 | +3.54% | |
| Bank Of America Corp | 0.00% | 1,397,050 | $11,064,636 | $11,455,810 | +$391,174 | +3.54% | |
| Ubs Group Ag | 0.00% | 1,300,913 | $10,303,231 | $10,667,487 | +$364,256 | +3.54% | |
| Ishara Investments Lp | 7.16% | 1,230,000 | $9,741,600 | $10,086,000 | +$344,400 | +3.54% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,224,398 | $9,697,232 | $10,040,064 | +$342,832 | +3.54% | |
| Kennedy Capital Management Llc | 0.17% | 1,209,068 | $9,575,819 | $9,914,358 | +$338,539 | +3.54% | |
| Dimensional Fund Advisors Lp | 0.00% | 1,073,639 | $8,503,221 | $8,803,840 | +$300,619 | +3.54% | |
| Knott David M Jr | 4.44% | 1,060,000 | $8,395,200 | $8,692,000 | +$296,800 | +3.54% | |
| Jpmorgan Chase & Co | 0.00% | 1,058,067 | $8,189,439 | $8,676,149 | +$486,710 | +5.94% | |
| Arrowstreet Capital, Limited Partnership | 0.00% | 972,880 | $7,705,210 | $7,977,616 | +$272,406 | +3.54% | |
| Granahan Investment Management, Llc | 0.25% | 898,753 | $7,118,124 | $7,369,775 | +$251,651 | +3.54% | |
| Norges Bank | 0.00% | 797,200 | $6,313,824 | $6,537,040 | +$223,216 | +3.54% | |
| Essex Investment Management Co Llc | 0.74% | 715,608 | $5,667,615 | $5,867,986 | +$200,371 | +3.54% | |
| Voya Investment Management Llc | 0.00% | 685,570 | $5,429,714 | $5,621,674 | +$191,960 | +3.54% | |
| Citadel Advisors Llc | 0.00% | 664,564 | $5,263,347 | $5,449,425 | +$186,078 | +3.54% | |
| Fmr Llc | 0.00% | 644,057 | $5,100,933 | $5,281,267 | +$180,334 | +3.54% | |
| Walleye Capital Llc | 0.02% | 611,296 | $4,841,464 | $5,012,627 | +$171,163 | +3.54% | |
| Deutsche Bank Ag\ | 0.00% | 529,443 | $4,193,189 | $4,341,433 | +$148,244 | +3.54% | |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | 0.00% | 668,074 | $3,874,829 | $5,478,207 | +$1,603,378 | +41.38% | |
| Bank Of New York Mellon Corp | 0.00% | 488,441 | $3,868,454 | $4,005,216 | +$136,762 | +3.54% | |
| First Trust Advisors Lp | 0.00% | 484,978 | $3,841,025 | $3,976,820 | +$135,795 | +3.54% | |
| Iht Wealth Management, Llc | 0.08% | 481,871 | $3,816,418 | $3,951,342 | +$134,924 | +3.54% | |
| Perceptive Advisors Llc | 0.06% | 467,013 | $3,698,743 | $3,829,507 | +$130,764 | +3.54% | |
| Royce & Associates Lp | 0.03% | 461,153 | $3,652,332 | $3,781,455 | +$129,123 | +3.54% | |
| Man Group Plc | 0.01% | 455,380 | $3,606,610 | $3,734,116 | +$127,506 | +3.54% | |
| Russell Investments Group, Ltd. | 0.00% | 440,731 | $3,490,591 | $3,613,994 | +$123,403 | +3.54% | |
| Bnp Paribas Financial Markets | 0.00% | 430,488 | $3,409,465 | $3,530,002 | +$120,537 | +3.54% | |
| State Of Wisconsin Investment Board | 0.01% | 427,513 | $3,385,903 | $3,505,607 | +$119,704 | +3.54% | |
| Y-Intercept (Hong Kong) Ltd | 0.06% | 411,346 | $3,257,860 | $3,373,037 | +$115,177 | +3.54% | |
| Squarepoint Ops Llc | 0.01% | 365,731 | $2,896,590 | $2,998,994 | +$102,404 | +3.54% |
Frequently asked questions about XERS
Who owns the most XERS stock?
The largest holders of XERS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for XERIS BIOPHARMA HOLDINGS INC (XERS).
Is XERS widely held by superinvestors?
Many widely followed stocks like XERS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly XERS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.